Vitalief Announces Caroline Brnich as NJBIZ 2024 “40 Under 40” Rising Star
July 24, 2024
Vitalief, an innovative healthcare consulting company dedicated to transforming clinical trials and empowering research, proudly announces that Caroline Brnich has been named a NJBIZ 2024 “40 Under 40” Rising Star.
Vitalief CEO Recognized in NJBIZ 2024 ICON HONORS
July 3, 2024
Vitalief is excited to announce that Chief Executive Officer David Moore has been recognized as an NJBIZ 2024 ICON HONOR recipient.
Vitalief Launches Vitalief Academy
June 26, 2023
Vitalief is excited to announce the launch of Vitalief Academy, a suite of services, content, and technologies that offer competency enrichment and targeted learning and development curricula for professionals.
Vitalief Launches Innovative Float Pool Services to Address Nagging Resourcing Challenges Across Research and Clinical Trials Industry
June 8, 2023
New Brunswick, New Jersey, June 8, 2023 – Vitalief, a leading consulting and functional service provider for research and clinical trial organizations, announced today the launch of its transformative Float Pool services. The offering is designed to revolutionize the way research and clinical trial teams manage their human resources, directly addressing the healthcare human capital epidemic.
Vitalief Announces New Clinical Trials Office and Study Activation Services
June 1, 2023
Vitalief, a leading consulting and functional service provider specializing in the research and clinical trial industry, is excited to announce the launch of its new Clinical Trials Office (CTO) and Study Activation services. The offerings encompass four key services: consulting, resourcing, managed services, and learning and development which are designed to address the most pressing challenges in clinical research.
Vitalief Names Dave Granese as Chief Financial Officer
September 7, 2022
Vitalief, a leading innovator in research and clinical trial solutions, is pleased to announce that Dave Granese has been appointed as Chief Financial Officer (CFO).
Vitalief Announces Appointment of Board of Directors
July 13, 2022
Vitalief, a leading innovator in research and clinical trial solutions, is pleased to announce the appointment of its Board of Directors.
Vitalief Completes Series A Funding Round
April 19, 2022
Vitalief, a leading innovator in research and clinical trial solutions, today announced the completion of a $2.75 million Series A funding round led by Tech Council Ventures.
Vitalief Appoints Judy Mimeault as Chief Operating Officer
December 15, 2021
Vitalief, a leading innovator in research and clinical trial solutions, is pleased to announce that Judy Mimeault has joined the team as Chief Operating Officer (COO).
Vitalief Launches as a Novel Research and Clinical Trial Solutions Company
December 10, 2021
Vitalief, an innovator in research and clinical trial solutions, formally launched today. The formation of Vitalief was driven by the significant challenges clinical research teams are facing.
